Wajd Alkabbani
Wajd Alkabbani publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Pharmacovigilance and Adverse Drug Reactions.
- World rank
- #1,745,084 of 7,710,434 ranked researchers
- Rank in Canada
- #58,208 of 183,316
- Works
- 62
- Citations
- 516
- Citations per work
- 8.3
What does Wajd Alkabbani research?
Wajd Alkabbani's work is mostly in Medicine (58%), Pharmacology, Toxicology and Pharmaceutics (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3658.4%
- Medicine3658.4%
- Everything else2235.3%
- Life Sciences46.3%
- 1Endocrinology, Diabetes and Metabolism35% of their works
- 2Surgery9% of their works
- 3Pulmonary and Respiratory Medicine6% of their works
- 4Toxicology6% of their works
- 5Family Practice4% of their works
- 6Oncology4% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacovigilance and Adverse Drug Reactions
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Medication Adherence and Compliance
- Bariatric Surgery and Outcomes
- Dementia and Cognitive Impairment Research
- Potassium and Related Disorders
Which keywords describe Wajd Alkabbani's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Type 2 Diabetes, Heart Failure, Cardiovascular Outcomes, Glucose Control, Diabetes and Health Outcomes.
- Renin-Angiotensin-Aldosterone System Inhibitors
- Hyperkalemia
- Treatment Adherence
- Medication Adherence
- Pharmacovigilance
- Critical Care
- Hypoglycemia
- Health Outcomes
- Glucose Control
- Heart Failure
- Insulin Therapy
- Glycemic Control
- Type 2 Diabetes
- Cardiovascular Outcomes
- Diabetes
- Continuous Glucose Monitoring
- Adverse Drug Reactions
- Hyperglycemia
- Bariatric Surgery
- Obesity
- Alzheimer's Disease
- Mild Cognitive Impairment
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Glycemic Control473 topics
- Insulin Therapy473 topics
- Type 2 Diabetes352 topics
- Heart Failure342 topics
- Cardiovascular Outcomes291 topic
- Glucose Control291 topic
- Diabetes172 topics
- Health Outcomes122 topics
- Continuous Glucose Monitoring111 topic
- Hypoglycemia111 topic
- Adverse Drug Reactions71 topic
- Critical Care71 topic
- Hyperglycemia71 topic
- Pharmacovigilance71 topic
- Bariatric Surgery61 topic
- Medication Adherence61 topic
- Obesity61 topic
- Treatment Adherence61 topic
- Alzheimer's Disease51 topic
- Hyperkalemia51 topic
- Mild Cognitive Impairment51 topic
- Renin-Angiotensin-Aldosterone System Inhibitors51 topic
Where does Wajd Alkabbani work?
Wajd Alkabbani's main affiliation in the publication record is University of Waterloo, Canada.
How many publications and citations does Wajd Alkabbani have?
OpenAlex counts 62 works and 516 citations for Wajd Alkabbani, an h-index of 14, ranking #1,745,084 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Wajd Alkabbani. Posts are plain text and can be reported.